These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17199095)

  • 1. Angiotensin II receptor blockade ameliorates mesangioproliferative glomerulonephritis in rats through suppression of CTGF and PAI-1, independently of the coagulation system.
    Liu N; Shimizu S; Ito-Ihara T; Takagi K; Kita T; Ono T
    Nephron Exp Nephrol; 2007; 105(3):e65-74. PubMed ID: 17199095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in rats.
    Liu N; Makino T; Nogaki F; Kusano H; Suyama K; Muso E; Honda G; Kita T; Ono T
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F612-20. PubMed ID: 15172885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive mechanisms of Sairei-to on mesangial matrix expansion in rat mesangioproliferative glomerulonephritis.
    Ono T; Liu N; Makino T; Nogaki F; Muso E; Honda G; Kita T
    Nephron Exp Nephrol; 2005; 100(3):e132-42. PubMed ID: 15824516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
    Mii A; Shimizu A; Masuda Y; Ishizaki M; Kawachi H; Iino Y; Katayama Y; Fukuda Y
    Lab Invest; 2009 Feb; 89(2):164-77. PubMed ID: 19139720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of KD3-671, an angiotensin II type 1 receptor antagonist, on anti-thy-1 nephritis in rats.
    Nagamatsu T; Oka T; Nagao T; Suzuki Y
    Biol Pharm Bull; 2003 Jun; 26(6):808-12. PubMed ID: 12808291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
    Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
    Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
    J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of coagulation pathway and factor Xa in rat mesangioproliferative glomerulonephritis.
    Nomura K; Liu N; Nagai K; Hasegawa T; Kobayashi I; Nogaki F; Tanaka M; Arai H; Fukatsu A; Kita T; Ono T
    Lab Invest; 2007 Feb; 87(2):150-60. PubMed ID: 17179958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mesangial Factor V expression in crescent formation in rat experimental mesangioproliferative glomerulonephritis.
    Ono T; Liu N; Makino T; Nogaki F; Nomura K; Muso E; Shimizu F; Honda G; Kita T
    J Pathol; 2004 Oct; 204(2):229-38. PubMed ID: 15376264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin reduces mesangial cell number and glomerular inflammation in experimental mesangioproliferative glomerulonephritis.
    Plank C; Hartner A; Klanke B; Geissler B; Porst M; Amann K; Hilgers KF; Rascher W; Dötsch J
    Kidney Int; 2005 Sep; 68(3):1086-95. PubMed ID: 16105039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
    Fan YY; Baba R; Nagai Y; Miyatake A; Hosomi N; Kimura S; Sun GP; Kohno M; Fujita M; Abe Y; Nishiyama A
    Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.
    Wu SH; Wu XH; Liao PY; Dong L
    Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
    Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis.
    Janssen U; Eitner F; Kunter U; Ostendorf T; Wolf G; Chaponnier C; Gabbiani G; Kerjaschki D; Floege J
    Nephron Exp Nephrol; 2003; 93(4):e158-67. PubMed ID: 12759577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
    Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
    Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of plasminogen activator-inhibitor-1 (PAI-1) during cellular remodeling in proliferative glomerulonephritis in the rat.
    Barnes JL; Mitchell RJ; Torres ES
    J Histochem Cytochem; 1995 Sep; 43(9):895-905. PubMed ID: 7642963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.